BEAM THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.51 USD | -0.27% |
|
+5.76% | -6.28% |
| 09-18 | JonesTrading Initiates Beam Therapeutics at Hold | MT |
| 08-06 | Beam Therapeutics Shares Edge Higher Despite Wider Q2 Loss, Lower Revenue | MT |
Chart calendar Beam Therapeutics Inc.
4ec.4rjSycFMA1Q-KUyiXAfXawu3kQ5Je-0m8cfBEHvUAaw.gYjqkJEOdAtncD3RO3WeAjjgy1l8CdVMk_GOWDWib_6Kz6WT8wlgGHZTfA~b7bb6e10b46f8c3621bf4edef32870d5
Upcoming events on Beam Therapeutics Inc.
Past events on Beam Therapeutics Inc.
| 2024-08-06 06:30 | Q2 2024 Earnings Release |
| 2024-06-14 12:00 | European Hematology Association Meeting - Abstrac No t: P1479 |
| 2024-06-06 13:30 | Jefferies Global Healthcare Conference - Fireside Chat |
| 2024-06-05 11:30 | Annual General Meeting |
| 2024-05-15 13:35 | RBC Capital Markets Global Healthcare Conference |
| 2024-05-07 06:30 | Q1 2024 Earnings Release |
| 2024-03-13 14:35 | Barclays Global Healthcare Conference |
| 2024-03-11 14:40 | Leerink Partners Global Biopharma Conference |
| 2024-03-06 12:50 | TD Cowen Health Care Conference |
| 2024-02-27 06:30 | Q4 2023 Earnings Release |
| 2024-02-08 10:30 | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-08 14:15 | JPMorgan Healthcare Conference |
| 2023-11-15 11:30 | Jefferies London Healthcare Conference |
| 2023-11-08 06:30 | Q3 2023 Earnings Release |
| 2023-10-24 | European Society of Gene & Cell Therapy Congress |
| 2023-09-26 10:00 | BMO BioPharma Virtual Spotlight Series |
| 2023-09-07 10:15 | Wells Fargo Healthcare Conference |
| 2023-09-07 08:50 | Citi BioPharma Conference |
| 2023-08-08 06:30 | Q2 2023 Earnings Release |
| 2023-06-06 11:30 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 51,8 12,5 316.19% | 60,9 54,2 12.37% | 378 93,7 303.31% | 49,9 | 57,9 | 58,9 |
|
EBITDA Million USD | Released Forecast Spread | -385 -383 -0.64% | -324 -332 2.22% | -156 -398 60.67% | -400 | -415 | -406 |
|
EBIT Million USD | Released Forecast Spread | -392 -387 -1.31% | -338 -336 -0.61% | -176 -409 56.84% | -424 | -441 | -469 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -371 -369 -0.42% | -260 -322 19.27% | -131 -356 63.12% | -391 | -410 | -442 |
|
Net income Million USD | Released Forecast Spread | -371 -367 -0.92% | -289 -337 14.25% | -133 -337 60.65% | -387 | -412 | -442 |
|
EPS USD | Released Forecast Spread | -5,77 -5,80 0.59% | -4,13 -4,85 14.77% | -1,72 -4,37 60.66% | -4,67 | -4,53 | -4,46 |
| Announcement Date | 28/02/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | Juni | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15,8 7,15 120.95% | 20,0 12,7 57.35% | 24,2 15,6 54.78% | 20,1 16,8 19.41% | 17,2 23,9 -28.04% | 316 33,7 839.01% | 7,41 14,7 -49.47% | 11,8 13,0 -9.77% | 14,7 | 14,2 | 14,0 | 14,0 | 14,3 | 14,3 |
|
EBITDA Million USD | Released Forecast Spread | -87,8 -70,1 -25.29% | -85,0 -95,2 10.69% | -97,3 -71,8 -35.49% | -103 -87,2 -18.26% | 138 -97,7 241.43% | -98,7 -109 9.84% | -99,3 -89,6 -10.8% | -94,2 | -96,9 | |||||
|
EBIT Million USD | Released Forecast Spread | -91,3 -91,8 0.59% | -89,0 -94,7 6.03% | -98,9 -95,3 -3.8% | -102 -106 3.68% | -108 -109 0.55% | 133 -108 222.95% | -104 -124 16.25% | -105 -101 -3.66% | -105 | -113 | -115 | -116 | -116 | -117 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -81,7 -93,8 12.94% | -37,3 -99,4 62.43% | -96,5 -94,1 -2.52% | -82,8 -109 23.84% | -96,1 -106 9.03% | 144 -78,3 284.23% | -98,7 -121 18.34% | -91,0 -92,9 2.06% | -96,6 | -108 | -113 | -114 | -115 | -116 |
|
Net income Million USD | Released Forecast Spread | -110 -90,8 -20.63% | -38,3 -95,4 59.81% | -96,5 -93,0 -3.67% | -82,8 -103 19.79% | -96,1 -97,1 1.08% | 143 -57,5 348.41% | -98,7 -119 17.27% | -91,1 -93,7 2.86% | -97,0 | -107 | -113 | -114 | -115 | -116 |
|
EPS USD | Released Forecast Spread | -1,56 -1,30 -19.76% | -0,54 -1,35 59.93% | -1,33 -1,33 -0.36% | -1,08 -1,39 22.27% | -1,22 -1,25 2.47% | 1,73 -0,81 314.15% | -1,21 -1,44 15.73% | -1,11 -1,12 0.88% | -1,15 | -1,21 | -1,15 | -1,14 | -1,11 | -1,11 |
| Announcement Date | 07/11/22 | 28/02/23 | 10/05/23 | 08/08/23 | 08/11/23 | 27/02/24 | 07/05/24 | 06/08/24 | - | - | - | - | - | - |
More events
Past sector events for Beam Therapeutics Inc.
| 2024-09-09 16:01 | ABIVAX: Q2 2024 Earnings Release |
| 2024-09-05 02:00 | GENUS PLC: Q4 2024 Earnings Release |
| 2024-08-29 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q2 2024 Earnings Release |
| 2024-08-29 02:00 | BIOARCTIC AB: Q2 2024 Earnings Release |
| 2024-08-28 19:27 | MESOBLAST LIMITED: Q4 2024 Earnings Release |
| 2024-08-28 | R&G PHARMASTUDIES CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-28 | MORPHOSYS AG: Q2 2024 Earnings Release |
| 2024-08-28 02:00 | PURETECH HEALTH PLC: Q2 2024 Earnings Release |
| 2024-08-27 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q2 2024 Earnings Release |
| 2024-08-27 04:00 | OCULIS HOLDING AG: Q2 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BEAM Stock
- Calendar Beam Therapeutics Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition